Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

February 24, 2020

Study Completion Date

December 30, 2025

Conditions
Lung Cancer Metastatic
Interventions
DRUG

Durvalumab

MEDI4736

DRUG

Tremelimumab

Tremelimumab

DRUG

Platinum-Based Drug

Pemetrexed, cisplatin, carboplatin or gemcitibine

Trial Locations (49)

2031

Prince of Wales Hospital, Randwick

2139

Concord Repatriation General Hospital, Concord

2170

Liverpool Cancer Therapy Centre, Liverpool Hospital, Liverpool

2217

St. George Hospital, Cancer Care Centre, Kogarah

2450

Coffs Habour Health Campus - NCCI, Coffs Harbour

2480

The Tweed Hospital, Lismore

2560

Campbelltown Hospital, Campbelltown

2751

Nepean Hospital, Kingswood

3065

St. Vincent's Hospital, Victoria Park

3121

Epworth HealthCare - Richmond, Richmond

3350

Ballarat Health Services, Ballarat

3690

Border Medical Oncology, Wodonga

4032

The Prince Charles Hospital, Chermside

4101

Mater Research Institute South Brisbane, South Brisbane

4102

Princess Alexandra Hospital, Brisbane

4215

Gold Coast University Hospital, Southport

4350

Toowoomba Hospital, Toowoomba

6008

Saint John of God Hospital Subiaco, Subiaco

7000

Royal Hobart Hospital, Hobart

T6G 1Z2

Cross Cancer Institute, Edmonton

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

E3B 5N5

Horizon Health Network, Fredericton

E1C 6Z8

The Moncton Hospital, Moncton

E1C 8X3

The Vitalite Health Network - Dr. Leon Richard, Moncton

E2L 4L2

Regional Health Authority B, Zone 2, Saint John

N1R 3G2

Cambridge Memorial Hospital, Cambridge

P3E 5J1

Health Sciences North, Greater Sudbury

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 2V7

Kingston Health Sciences Centre, Kingston

N2G 1G3

Grand River Regional Cancer Centre, Kitchener

L3Y 2P9

Stronach Regional Health Centre at Southlake, Newmarket

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

L2S 0A9

Niagara Health System, St. Catharines

M2K 1E1

North York General Hospital, Toronto

M3M 0B2

Humber River Regional Hospital, Toronto

M4C 3E7

Michael Garron Hospital, Toronto

M5G 2M9

University Health Network, Toronto

N8W 2X3

Windsor Regional Cancer Centre, Windsor

C1A 8T5

PEI Cancer Treatment Centre, Charlottetown

H7M 3L9

Hopital de la Cite-de-la-Sante, Laval

H2X 3E4

CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal

H3T 1E2

The Jewish General Hospital, Montreal

G1J 1Z4

CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec

G1V 4G5

University Institute of Cardiology and, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

lead

Canadian Cancer Trials Group

NETWORK